scispace - formally typeset
M

Masaru Uyeda

Researcher at Kumamoto University

Publications -  116
Citations -  1246

Masaru Uyeda is an academic researcher from Kumamoto University. The author has contributed to research in topics: Streptomyces & Topoisomerase. The author has an hindex of 19, co-authored 116 publications receiving 1179 citations. Previous affiliations of Masaru Uyeda include Fukuoka University.

Papers
More filters
Journal ArticleDOI

Anti-herpes virus activity of Solanum steroidal glycosides

TL;DR: Anti-herpes simplex virus type 1 (HSV-1) activity of typical steroidal glycosides with the frameworks of spirostane (including nuatigenin glycoside), furostane, solasodane, tomatidane and ergostane obtained from Solanum plants was examined.
Journal ArticleDOI

Anti-herpes virus type 1 activity of oleanane-type triterpenoids.

TL;DR: The anti-herpes simplex virus type 1 (HSV-1) activity of 15 oleanan-type triterpenoides including glycyrrhizin and its sapogenol was examined and their structure-activity relationships were discussed.
Journal ArticleDOI

A new lignan glycoside and phenylethanoid glycosides from Strobilanthes cusia BREMEK.

TL;DR: Lupeol showed anti-HSV-1 activity and showed 100% inhibition of virus plaque formation at 58.7 microM, and two new phenylethanoid glycosides were found together with five known compounds as chemical constituents of Strobilanthes cusia root.
Journal ArticleDOI

Inhibitory activities of (-)-epigallocatechin-3-O-gallate against topoisomerases I and II

TL;DR: The substitution of gallic acid at the 3 position of (-)-epigallocatechin-3-O-gallate (EGCG) increased the inhibition against topoisomerase I from calf thymus gland and topoisomease II from human placenta, and the substitution of a hydroxyl group at the3' position increased the inhibited against the topoisomersase I.
Journal ArticleDOI

Inhibitory properties of antitumor prostaglandins against topoisomerases.

TL;DR: In this paper, the potential order of inhibitory activity of the Prostaglandins resembling that of the antitumor activity was investigated and Δ12,14-PGJ2 was found to be a topo inhibitor of the cleavable complex-nonforming type without DNA intercalation.